Scholarlink

<p><i>Candida auris</i>, an increasingly prevalent fungal pathogen, requires both rapid identification and antifungal susceptibility testing to enable proper treatment. This study introduces digital SHERLOCK (dSHERLOCK), a platform that combines CRISPR/Cas nucleic acid detection, single-template quantification and real-time kinetics monitoring. Assays implemented on this platform display excellent sensitivity to <i>C. auris</i> from major clades 1–4, while maintaining specificity when challenged with common environmental and pathogenic fungi. dSHERLOCK detects <i>C. auris</i> within 20 min in minimally processed swab samples and achieves sensitive quantification (1 c.f.u. µl<sup>−1</sup>) within 40 min. To address antifungal susceptibility testing, we develop assays that detect mutations that are commonly associated with azole and echinocandin multidrug resistance. We use machine learning and real-time monitoring of reaction kinetics to achieve highly accurate simultaneous quantification of mutant and wild-type <i>FKS1</i> SNP alleles in fungal populations with mixed antifungal susceptibility, which would be misdiagnosed as completely susceptible or resistant under standard reaction conditions. Our platform’s use of commercially available materials and common laboratory equipment makes <i>C. auris</i> diagnostics widely deployable in global healthcare settings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Digital CRISPR-based diagnostics for quantification of Candida auris and resistance mutations

  • 期刊论文

  • 发表日期：

    2026年1月14日

查看全文
  • Justin C. Rolando,
  • Anton Thieme,
  • Nicole E. Weckman,
  • Nayoung Kim,
  • Helena de Puig,
  • Xiao Tan,
  • Emily Cotnoir,
  • Vishnu Chaturvedi,
  • James J. Collins,
  • David R. Walt

摘要

Candida auris, an increasingly prevalent fungal pathogen, requires both rapid identification and antifungal susceptibility testing to enable proper treatment. This study introduces digital SHERLOCK (dSHERLOCK), a platform that combines CRISPR/Cas nucleic acid detection, single-template quantification and real-time kinetics monitoring. Assays implemented on this platform display excellent sensitivity to C. auris from major clades 1–4, while maintaining specificity when challenged with common environmental and pathogenic fungi. dSHERLOCK detects C. auris within 20 min in minimally processed swab samples and achieves sensitive quantification (1 c.f.u. µl−1) within 40 min. To address antifungal susceptibility testing, we develop assays that detect mutations that are commonly associated with azole and echinocandin multidrug resistance. We use machine learning and real-time monitoring of reaction kinetics to achieve highly accurate simultaneous quantification of mutant and wild-type FKS1 SNP alleles in fungal populations with mixed antifungal susceptibility, which would be misdiagnosed as completely susceptible or resistant under standard reaction conditions. Our platform’s use of commercially available materials and common laboratory equipment makes C. auris diagnostics widely deployable in global healthcare settings.